West Pharmaceutical Services | WST - Betriebsergebnis

Aktienkurs
306.16
Täglich Wechseln
-3.54 -1.14%
Monatlich
23.94%
Jährlich
42.70%
Q2 Prognose
299.61




Betriebsergebnis Veränderung Datum
Align Technology USD 224.71M 40.06M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dentsply International USD 538M 26M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Neogen USD -3.3M 2.08M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD -37.3M 667.5M 2025-12
Repligen USD 19.97M 7.29M 2025-12
Rockwell Medical USD 515K 1.84M 2024-06
Solventum Corp USD 105M 1.58B 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Utah Medical Products USD 2.44M 1.32M 2025-12
West Pharmaceutical Services USD 177.1M 14.6M 2026-03